1. 1. GRIESINGER, Georg, et al. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial. Human Reproduction, 2018, 33.12: 2212-2221.‏. 2. FERRARETTI, Anna Pia, et al. No need for luteal phase support in IVF cycles after mild stimulation: proof-of-concept study. Reproductive biomedicine online, 2017, 34.2: 162-165.‏. 3. WATTERS, Marianne, et al. Short Versus Extended Progesterone Supplementation for Luteal Phase Support in fresh IVF cycles: a systematic review and meta-analysis. Reproductive BioMedicine Online, 2019.‏. 4. THOMSEN, Lise Haaber, et al. Reply: Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer. Human Reproduction, 2018.‏. 5. MENDOZA-TESARIK, Raquel, et al. GnRH agonist treatment of luteal phase deficiency in HCG-triggered IVF cycles: a matched case-control study. Reproductive biomedicine online, 2019, 39.2: 225-230.‏. 6. WEEDIN, Elizabeth, et al. Luteal-phase progesterone supplementation in non-IVF treatment: a survey of physicians providing infertility treatment. Human Fertility, 2019, 1-7.‏ 7. Brown S, Hutton B, Clifford T, Coyle D, Grima D, Wells G, Cameron C. A Microsoft-Excel-based tool for running and critically appraising network meta-analyses—an overview and application of NetMetaXL. Systematic reviews. 2014 Dec;3(1):1-1. 8. Geber S, Moreira AC, de Paula SO, Sampaio M. Comparison between two forms of vaginally administered progesterone for luteal phase support in assisted reproduction cycles. Reproductive biomedicine online. 2007 Jan 1;14(2):155-8. 9. Simunic V, Tomic V, Tomic J, Nizic D. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support. Fertility and sterility. 2007 Jan 1;87(1):83-7. 10. Kleinstein J, Luteal Phase Study Group. Efficacy and tolerability of vaginal progesterone capsules (Utrogest™ 200) compared with progesterone gel (Crinone™ 8%) for luteal phase support during assisted reproduction. Fertility and sterility. 2005 Jun 1;83(6):1641-9. 11. Tay PY, Lenton EA. The impact of luteal supplement on pregnancy outcome following stimulated IVF cycles. Medical Journal of Malaysia. 2005 Jun 1;60(2):151. 12. Ng EH, Chan CC, Tang OS, Ho PC. A randomized comparison of side effects and patient convenience between Cyclogest® suppositories and Endometrin® tablets used for luteal phase support in IVF treatment. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2007 Apr 1;131(2):182-8. 13. Ludwig M, Schwartz P, Babahan B, Katalinic A, Weiss JM, Felberbaum R, Al-Hasani S, Diedrich K. Luteal phase support using either Crinone® 8% or Utrogest®: results of a prospective, randomized study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2002 Jun 10;103(1):48-52. 14. Tomic V, Tomic J, Klaic DZ, Kasum M, Kuna K. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015 Mar 1;186:49-53. 15. Ho CH, Chen SU, Peng FS, Chang CY, Yang YS. Luteal support for IVF/ICSI cycles with Crinone 8%(90 mg) twice daily results in higher pregnancy rates than with intramuscular progesterone. Journal of the Chinese Medical Association. 2008 Aug 1;71(8):386-91. 16. Lockwood G, Griesinger G, Cometti B, et al. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study. Fertil Steril. 2014;101:112–119.e113. 17. Baker VL, Jones CA, Doody K, et al. A randomized, controlled trial comparing the efficacy and safety of aqueous subcutaneous progesterone with vaginal progesterone for luteal phase support of in vitro fertilization. Hum Reprod. 2014;29:2212–2220. 18. Zaman AY, Coskun S, Alsanie AA, Awartani KA. Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy. Fertility research and practice. 2017 Dec;3(1):1-6. 19. Doblinger J, Cometti B, Trevisan S, Griesinger G. Subcutaneous progesterone is effective and safe for luteal phase support in IVF: an individual patient data meta-analysis of the phase III trials. PLoS One. 2016 Mar 18;11(3):e0151388. 20. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein MD. Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. Fertility and sterility. 2008 Feb 1;89(2):485-7. 21. Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M. Patterns of luteal phase bleeding in in vitro fertilization cycles supplemented with Crinone vaginal gel and with intramuscular progesterone – impact of luteal estrogen: prospective, randomized study and post hoc analysis. Fertil Steril. 2011;95:617–20 22. Chi HB, Liu NN, Li R, Tao LY, Chen LX, Qiao J. Comparison of vaginal gel and intramuscular progesterone for in vitro fertilization and embryo transfer with gonadotropin-releasing hormone antagonist protocol. Chinese medical journal. 2018 Jul 5;131(13):1557. 23. Berjis K, Sarem A, Moaya M, Alaiha NM. Comparison of Intramuscular and Intravaginal Progesterone for Luteal Phase Support in IVF Cycles: a randomized clinical trial. Journal of Family and Reproductive Health. 2008:99-102. 24. Nosarka S, Kruger T, Siebert I, Grové D. Luteal phase support in in vitro fertilization: meta-‎analysis of randomized trials. Gynecologic and obstetric investigation. 2005;60(2):67-74.‎ 25. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Human Reproduction. 2002 Sep 1;17(9):2287-99. 26. Smitz j, D., Camusm, The luteal phase and early pregnancy aftercombined GnRH agonist. HMG treatment for superovulation in IVF of GIFT. Hum Repord. 1988 Jul ;3(s) :585¬90. 27. Watters M, Noble M, Child T, Nelson S. Short versus extended progesterone supplementation for luteal phase support in fresh IVF cycles: a systematic review and meta-analysis. Reproductive biomedicine online. 2020 Jan 1;40(1):143-50. 28. Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C, Olofsson JI, Driessen S, Tournaye H. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis. PLoS One. 2020 Nov 4;15(11):e0241044. 29. Salehpour S, Tamimi M, Saharkhiz N. Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial. Iranian journal of reproductive medicine. 2013 Nov;11(11):913.c